Increased Protein Stability and Interleukin-2 Production of a LAT(G131D)Variant With Possible Implications for T Cell Anergy by Arbulo Echevarria, Mikel M. et al.
fcell-08-561503 September 11, 2020 Time: 2:2 # 1
BRIEF RESEARCH REPORT




University of Malaga, Spain
Reviewed by:
Kamalakannan Rajasekaran,
Genentech Inc., United States
Adam G. Schrum,





This article was submitted to
Signaling,
a section of the journal
Frontiers in Cell and Developmental
Biology
Received: 12 May 2020
Accepted: 13 August 2020
Published: 11 September 2020
Citation:
Arbulo-Echevarria MM,
Vico-Barranco I, Narbona-Sánchez I,
García-Cózar F, Miazek A and
Aguado E (2020) Increased Protein
Stability and Interleukin-2 Production
of a LATG131D Variant With Possible
Implications for T Cell Anergy.
Front. Cell Dev. Biol. 8:561503.
doi: 10.3389/fcell.2020.561503
Increased Protein Stability and
Interleukin-2 Production of a
LATG131D Variant With Possible
Implications for T Cell Anergy
Mikel M. Arbulo-Echevarria1, Inmaculada Vico-Barranco1, Isaac Narbona-Sánchez1,
Francisco García-Cózar1,2, Arkadiusz Miazek3 and Enrique Aguado1,2*
1 Institute of Biomedical Research Cadiz (INIBICA), Cádiz, Spain, 2 Department of Biomedicine, Biotechnology and Public
Health (Immunology), University of Cádiz and Puerto Real University Hospital Research Unit, Cádiz, Spain, 3 Department
of Biochemistry and Molecular Biology, Wrocław University of Environmental and Life Sciences, Wrocław, Poland
The adaptor LAT plays a crucial role in the transduction of signals coming from the
TCR/CD3 complex. Phosphorylation of some of its tyrosines generates recruitment sites
for other cytosolic signaling molecules. Tyrosine 132 in human LAT is essential for PLC-γ
activation and calcium influx generation. It has been recently reported that a conserved
glycine residue preceding tyrosine 132 decreases its phosphorylation kinetics, which
constitutes a mechanism for ligand discrimination. Here we confirm that a LAT mutant
in which glycine 131 has been substituted by an aspartate (LATG131D) increases
phosphorylation of Tyr132, PLC-γ activation and calcium influx generation. Interestingly,
the LATG131D mutant has a slower protein turnover while being equally sensitive to Fas-
mediated protein cleavage by caspases. Moreover, J.CaM2 cells expressing LATG131D
secrete greater amounts of interleukin-2 (IL-2) in response to CD3/CD28 engagement.
However, despite this increased IL-2 secretion, J.CaM2 cells expressing the LATG131D
mutant are more sensitive to inhibition of IL-2 production by pre-treatment with anti-
CD3, which points to a possible role of this residue in the generation of anergy.
Our results suggest that the increased kinetics of LAT Tyr132 phosphorylation could
contribute to the establishment of T cell anergy, and thus constitutes an earliest known
intracellular event responsible for the induction of peripheral tolerance.
Keywords: LAT, TCR, phosphorylation, anergy, IL-2 (interleukin-2)
INTRODUCTION
After the specific recognition of a peptide antigen bound to an MHC molecule on the surface
of an Antigen Presenting Cell, a cascade of intracellular signaling events are triggered in T
lymphocytes (Malissen and Bongrand, 2015; Alcover et al., 2018; Courtney et al., 2018). The
transmembrane adaptor LAT (Linker for the Activation of T cells) constitutes a major ZAP-70
substrate, and initiates most of the intracellular events that characterize the T cell receptor (TCR)
signaling pathway (Weber et al., 1998; Zhang et al., 1998). Early on after initial LAT cloning
and characterization, experiments performed with the J.CaM2 LAT-deficient T cells analyzed the
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contribution of some of the nine conserved LAT tyrosines to
the TCR/CD3 signaling cascade (Finco et al., 1998; Zhang et al.,
2000; Lin and Weiss, 2001; Paz et al., 2001). Those early works
showed that the three most distal tyrosines (171, 191 and 226 in
the human form of LAT) are necessary for Grb2-SOS and Gads-
SLP76 binding and Erk activation and that the sixth tyrosine
residue (132 in human LAT) is essential for PLC-γ1 binding
and activation and calcium influx generation. Moreover, the
phenotype of LAT-knockout (KO) mice revealed the essential
role of this molecule for the transduction of intracellular signals
emanating from the pre-TCR, since thymic development was
completely blocked at the CD4-CD8- Double Negative (DN)
stage (Zhang et al., 1999).
Therefore, TCR engagement triggers the assembly of a LAT
signalosome linking the TCR to activatory signaling pathways
that govern T-cell development and activation (Malissen et al.,
2005). However, two LAT-knockin (KI) strains of mice harboring
point mutations in the four most distal tyrosines developed
lymphoproliferative disorders involving helper T (TH) cells
(Aguado et al., 2002; Sommers et al., 2002; Nunez-Cruz et al.,
2003). The analysis of those mice strains revealed for the first time
that the LAT adaptor acts not only as a transducer of activation
signals, but also constitutes a negative regulator of TCR signaling
and T-cell homeostasis. One of these strains of mice had a Tyr
to Phe mutation in tyrosine 136 of LAT (mouse ortholog of
human tyrosine 132, LATY136F KI), and presented a paradoxical
phenotype with a lymphoproliferative disorder of polyclonal
CD4 T cells along with high Th2 cytokine production, despite a
reduction in thymic development (Aguado et al., 2002; Sommers
et al., 2002). The phenotype of these mice constituted the first
evidence of a special inhibitory function for LAT, mainly played
by the sixth tyrosine residue.
The order of signaling events taking place after TCR
engagement is critical for productive immune responses. Lck
initiates intracellular signaling in T cells by phosphorylating
CD3 and ζ-chain ITAMs, leading to ZAP-70 recruitment and
activation (Chan et al., 1991; Wange et al., 1993; Iwashima et al.,
1994). Once activated ZAP-70, and not Lck, phosphorylates LAT
and SLP-76 tyrosines by utilizing an electrostatic mechanism that
favors phosphorylation of tyrosines surrounded by negatively
charged residues, and excludes phosphorylation of tyrosines close
to positively charged amino acids (Shah et al., 2016, 2018).
Tyrosine residues 127, 171, 191, and 226 of human LAT are all
preceded by aspartic or glutamic acid residues, and, as shown
by means of an approach using bacterial surface-display, cell
sorting, and deep sequencing, these tyrosines are efficiently
phosphorylated by ZAP-70. However, tyrosine 132 of LAT is
preceded by a well-conserved glycine residue, which should
preclude its efficient phosphorylation, and so PLC-γ activation,
calcium influx generation, and, ultimately, the activation of T
lymphocytes. Indeed, in agreement with such a hindrance, in
both Jurkat cells and primary human T cells, the kinetics of
tyrosine 132 phosphorylation of LAT is much slower than the one
of tyrosine 191 (Houtman et al., 2005). This is bewildering, given
the essential role of tyrosine 132 phosphorylation for complete
T cells activation (Zhang et al., 2000; Lin and Weiss, 2001; Paz
et al., 2001; Aguado et al., 2002; Sommers et al., 2002). Recent
work has shown that glycine 131 mutation by an aspartate residue
in LAT increases LAT-Y132 phosphorylation, but not the one
of tyrosines 171, 191 or 226 (Lo et al., 2019). Moreover, more
distal signaling events are also increased in cells expressing the
LATG131D mutant, for example, PLC-γ phosphorylation, Ca2+
influx, Erk phosphorylation or CD69 expression. Interestingly,
Lo et al. demonstrate in this work that cells expressing the
LATG131D mutant responded with greater intensity to lower
anti-CD3 concentrations than did wild-type cells, and the same
behavior was observed for low-affinity ligands in Jurkat cells
expressing the OTI TCR, or primary T cells from a mouse strain
expressing a floxed Lat allele, which allowed authors to delete
endogenous LAT expression and express wild-type LAT or a
LATG131D mutant. Lentiviral expression in mouse primary cells
of a LATG131D mutant also increased the production of IFN-
γ, which constitutes a piece of evidence that the brake imposed
by Gly 131 has effects in the final activation of T lymphocytes.
However, Weiss and collaborators did not analyze the production
of IL-2 in either Jurkat cells or primary cells. This is of relevance
since the increase in calcium responses shown by cells expressing
LATG131D may induce a greater production of this cytokine.
In the present report, we analyze the effects of expressing a
LATG131D mutant in the J.CaM2 LAT deficient cell line. We verify
the findings of Lo et al., showing that this LAT mutant induces
increased tyrosine phosphorylation of LAT specifically at residue
132, increased phosphorylation of PLC-γ and Ca2+ responses
after CD3 stimulation. Moreover, we observe an increase in
LAT protein stability, despite normal Fas-mediated cleavage, and
augmentation of IL-2 production after CD3/CD28 cross-linking.
Interestingly, J.CaM2 cells expressing the LATG131D mutant are
more sensitive to inhibition of IL-2 production by pre-treatment
with anti-CD3, which points to a possible role of this residue in
the generation of anergy.
METHOD
Antibodies and Reagents
The anti-Fas (IgM) antibody was from Merck-Millipore; anti-
LAT LAT-01 mAb was from EXBIO (Praha, Czech Republic);
anti-LAT 11B.12, anti-PLC- γ, anti-PTP1B, and anti-caspase-3
monoclonal antibodies were from Santa Cruz Biotechnology
(Heidelberg, Germany); antibodies binding phospho-Erk,
β-actin, phospho-PLC-γ1-Tyr783 and phospho-LAT-Tyr171
were from Cell Signaling Technology; anti-6His-HRP antibody
and anti-phospho-LAT-Tyr132 were from Abcam (Cambridge,
United Kingdom). The protein synthesis inhibitor cycloheximide
was purchased from Merck-Millipore. Stimulations were
performed with the anti-human CD3 OKT3 monoclonal
antibody (eBioscience).
Enzyme−Linked Immunosorbent Assay
(ELISA) and Anergy Induction
IL-2 release from lentivirally transduced J.CaM2 cells was
measured by human IL−2 ELISA set (MAX Standard, Biolegend,
Fell, Germany), using 96−well Nunc MaxiSorp microtiter plates.
Supernatants of resting or activated cells were analyzed in
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comparison to a standard curve of IL-2. Absorbance was
determined using a Synergy MX Multi-Mode Reader (Biotek,
Bad Friedrichshall, Germany) set to 405 and 450 nm. For anergy
induction, 24 well plates were coated overnight at 4◦C with 10,
2, 0.5, or 0.2 µg/ml OKT3 mAb in Tris 0.1 M buffer (pH 8.2;
200 µl/well). After washing three times with phosphate−buffered
saline (PBS), cells expressing wild-type or the mutant form of
LAT were incubated overnight and then stimulated in 96 well
plates with anti-CD3/CD28 microbeads (at a bead-to-cell ratio
of 3:1) for 48 h. Supernatants were analyzed by the human
IL−2 ELISA set.
Cell Culture
The LAT-deficient J.CaM2 cell line was generously provided
by Dr. Arthur Weiss, University of California, San Francisco
(CA, United States). Cells were grown in complete RPMI
1640 medium (Lonza) supplemented with 10% FCS (Lonza)
and 2 mM L-glutamine at 37◦C in a humidified atmosphere
containing 10% CO2.
Mutagenesis and Lentiviral Transduction
LAT cDNA cloning was performed as previously described
(Garcia-Blesa et al., 2013). Site-directed mutagenesis was
performed to change the sequence coding for glycine 131. Coding
sequences in the plasmids were verified by sequencing and then
subcloned in frame with GFP in the SIN lentiviral transfer
plasmid pHR’SINcPPT-Blast through site-specific recombination
(Gateway LR Clonase, Invitrogen). Lentiviral supernatants were
generated as previously described (Garcia-Blesa et al., 2013) and
used to induce expression of WT-LAT or the LAT-NIL mutant
in J.CaM2 cells. Blasticidin selection (20 µg/ml) was applied to
transduced cells after 72 h of culture, and the expression of GFP
was analyzed using FACS analysis (CytoFLEX, Beckman Coulter).
Preparation of Cell Lysates and Western
Blotting
Lentivirally transduced J.CaM2 cells were starved in RPMI 1640
without FCS for 18 h before being stimulated with anti-CD3 mAb
at 37◦C. Cells were then lysed at 2.0× 107 cells/ml in 2X Laemmli
buffer, followed by incubation at 99◦C for 5 min and sonication.
For anti-Fas stimulation, cells were incubated with 100 ng/ml of
anti-Fas mAb at 1 × 106 cells/ml in RPMI 1640, supplemented
with 10% FCS, and then pelleted and lysed as described above. For
Western blotting, whole-cell lysates were separated by SDS-PAGE
and transferred to PVDF membranes, which were incubated with
the indicated primary antibodies, followed by the appropriate
secondary antibody conjugated to IRDye 800CW (Li-Cor,
Lincoln, NE, United States) or horseradish peroxidase (HRP).
Reactive proteins were visualized using the Odyssey CLx Infrared
Imaging System (Li-Cor) or by enhanced chemiluminescence
(ECL) acquired in a ChemiDoc Touch Imaging System (Bio-Rad
Laboratories). For reprobing, PVDF membranes were incubated
for 10 min at room temperature with WB Stripping Solution
(Nacalai Tesque, Kyoto, Japan), followed by a TTBS wash. For
the cycloheximide chase assay, cells were treated with 0.1 mM
cycloheximide for up to 10 h. At the indicated time points, cell
samples were obtained and lysed in 2X Laemmli buffer, and
LAT protein levels were determined by immunoblotting and
quantified by densitometry.
Ca2+ Mobilization
Measurement of intracellular free Ca2+ was carried out
using Indo-1 AM (acetoxymethyl) (2 µM; Molecular Probes,
Invitrogen) as previously described (Garcia-Blesa et al., 2013).
Calcium measurements were performed using a Synergy MX
Multi-Mode Reader (Biotek) at 37◦C. Cells were excited by
light at a wavelength of 340 nm, and the fluorescence emitted
at 405 and 485 nm was collected alternately per second.
Calcium mobilization was evaluated by the ratio of 405/485 nm
fluorescence signal.
Statistical Analysis
Western blots were densitometrically quantified, and statistics
were performed with Microsoft Excel using a two-tailed t-test.
Levels of significance p < 0.05 are presented as ∗.
RESULTS AND DISCUSSION
Generation of Lentiviral Transfectants of
J. CaM2 Cells Expressing Wild-Type LAT
and the LATG131D Mutant
To study the role of the conserved glycine residue preceding
tyrosine 132 in LAT we generated lentiviral plasmids to express
wild-type LAT or a LATG131D mutant in J.CaM2 cells, as
previously described (Arbulo-Echevarria et al., 2016, 2018). This
would allow us to verify the effects observed by Lo et al. (2019).
in Jurkat cells in which CRISPR was performed to eliminate
the Lat gene in both chromosomes, and also address other
questions of interest. We designed lentiviral vectors containing
the coding region of wild-type or the mutant LAT fused
to a 6-His tag, followed by an IRES sequence and a GFP
reporter (Supplementary Figure S1A). Lentiviral supernatants
were generated and used for infection of J.CaM2 cells obtaining
transfection levels always greater of 75% of cells, as measured
by GFP expression (Supplementary Figure S1B). GFP levels
were always similar in cells expressing wild-type LAT and the
LATG131D mutant, although sometimes levels of GFP were
slightly higher in J.CaM2 cells expressing wild-type LAT. To
assure that any possible difference in the responses observed in
cells expressing WT-LAT and LATG131D mutant was not due to
differential expression of the TCR/CD3 complex, we analyzed
by flow cytometry CD3 expression. As shown in Supplementary
Figure S1B, CD3 expression was indistinguishable in J.CaM2
cells expressing WT-LAT and the LATG131D mutant. Next, to
determine LAT levels in lentivirally transduced cells, Western
blot analysis was performed with non-transduced JCaM2 cells
or expressing WT-LAT or LATG131D mutant. As it can be seen
in Supplementary Figure S1C, Western blot performed with
the mAb LAT01 did not detect LAT expression in J.CaM2
cells transduced with the LATG131D mutant (Supplementary
Figure S1C, left panel). This result was unexpected since these
Frontiers in Cell and Developmental Biology | www.frontiersin.org 3 September 2020 | Volume 8 | Article 561503
fcell-08-561503 September 11, 2020 Time: 2:2 # 4
Arbulo-Echevarria et al. LATG131D Mutation Favors Anergy
cells had similar GFP expression levels than WT-LAT expressing
cells. Western blots performed with an anti-6His mAb showed
bands of similar intensity in both WT-LAT and LATG131D
transduced cells (Supplementary Figure S1C, middle panel),
supporting that the LATG131D mutant was expressed at similar
levels than WT-LAT but was not recognized by the LAT01 mAb.
Indeed, a different mAb (11B.12, Supplementary Figure S1C,
right panel) showed similar reactivity in both types of cells.
Therefore, it seems that the Gly to Asp amino acid substitution
performed in the LATG131D mutant affects the epitope recognized
by LAT01 mAb, and may constitute a way to differentiate wild-
type LAT and the LATG131D mutant.
Mutation of Gly 131 to Asp of LAT
Increases Intracellular Signaling
To verify whether the mutation of glycine 131 to aspartate
reproduced the effects observed by Lo et al. (2019), we performed
anti-CD3 stimulations in WT-LAT and LATG131D expressing
J.CaM2 cells. As previously reported, the substitution of glycine
at position 131 with an aspartate residue increased the kinetics
and intensity of phosphorylation of LAT tyrosine 132, since
phosphorylation 3 and 10 min after CD3 treatment induced an
statistically significant increase of phosphorylation (Figure 1A).
However, phosphorylation of tyrosine 171 was similar in both
WT-LAT and LATG131D expressing J.CaM2 cells, confirming the
specificity of the negative effect of the glycine residue in the
phosphorylation of LAT Y132 (Supplementary Figure S2A).
Next, given the specific increase in phosphorylation of
LAT Y132 after CD3 stimulation, we wondered if this would
transduce enhanced downstream signals. Therefore, we analyzed
the effect of replacing G131 by an aspartate residue on PLC-
γ1 activation, which can be monitored by the phosphorylation
of its tyrosine residue 783 (Wang et al., 1998). As can be seen
in Supplementary Figure S2B, anti-CD3 treatment induced
increased phosphorylation of PLC-γ1 in LATG131D expressing
J.CaM2 cells at all the time points analyzed, supporting the
view that the increased kinetics of LAT Y132 phosphorylation
is enough to induce augmented downstream signals. Next we
analyzed whether the mutation of G131 of LAT affected calcium
influx generation. Indo-1AM labeled cells were stimulated
with 1 µg/ml OKT3 mAb, and Ca2+ influx was analyzed.
Interestingly, even at high doses of anti-CD3 (1 µg/ml) the
calcium response in J.CaM2 cells expressing the LATG131D
mutant was slightly higher than the one observed in WT-LAT
expressing cells (Figure 1B). We also performed experiments
with lower doses of OKT3 mAb, to corroborate previous results
showing the difference in Ca2+ responses between T cells
expressing LATG131D and WT-LAT were greater at low doses of
the antibody. As it can be seen in Supplementary Figure S2C,
stimulation with 0.5 µg/ml and 0.12 µg/ml of OKT3 showed
greater differences between WT-LAT and LATG131D expressing
cells. Therefore, our results confirm that glycine 131 acts as
a negative regulator of LAT Y132 phosphorylation, and thus
of TCR signaling.
To validate the negative role of G131 residue of LAT, we
also analyzed Erk phosphorylation in WT-LAT and LATG131D
expressing cells (Figure 1C). Again, mutation of glycine 131
to aspartate induced increased kinetics and intensity of Erk
phosphorylation, with statistical significance at the 3 min
time point (Figure 1C, lower diagram). Altogether, these
data confirm that the LATG131D mutation releases the brake
imposed on the TCR/CD3 signaling cassette, as previously
observed by Lo et al. (2019).
Impact of Glycine 131 Substitution on
LAT Cleavage and Protein Stability
Our group has previously demonstrated that LAT undergoes
a proteolytic cleavage in T cells receiving proapoptotic stimuli
(Garcia-Blesa et al., 2013; Klossowicz et al., 2013). Given that
glycine in position 131 is close to one of the described cleavage
points in LAT (aspartate 126), we decided to verify if the
substitution of G131 by an aspartic acid residue modifies
Fas-dependent LAT cleavage. Therefore, we treated lentivirally
transduced J.CaM2 cells with an anti-Fas antibody for 4 h at
37◦C. As it can be seen in Figure 2A, cleavage of both WT-LAT
and LATG131D mutant generated two proteolytic fragments of the
same electrophoretic mobility and similar intensity. Therefore,
these results show that the LATG131D mutant is equally sensitive
to Fas-mediated proteolytic cleavage as WT-LAT.
We have previously shown that a functional isoform of LAT
originated from an intron six retention event, and that can be
detected in human and other mammalian species at the RNA
level, shows a shorter half-life than the canonical LAT isoform
(Klossowicz et al., 2014). More recently we have described that
mutation of a stretch of negatively charged residues, encoded by
exon seven of human LAT, also affects LAT stability, since the
substitution of this fragment with a stretch of non-charged amino
acids significantly decreases LAT stability (Arbulo-Echevarria
et al., 2018). Given that those LAT sequence modifications
affected residues from position 113 to 126, we wondered if the
substitution of glycine in position 131 of LAT would modify LAT
stability. Consequently, we cultured J.CaM2 cells expressing WT-
LAT or LATG131D in the presence of the translational inhibitor
cycloheximide, and then cells were collected at specific time
points and lysed. Surprisingly, Western blot analysis showed that
the LATG131D mutant is degraded with slower kinetics than WT-
LAT (Figure 2B, upper panel). Densitometric analysis of five
independent experiments showed that LATG131D has increased
stability in comparison with WT-LAT, with statistical significance
after 4 h of cycloheximide treatment (Figure 2B, lower panel).
This observation is in agreement with our previous reports about
the role of this region on LAT turnover and could be, at least in
part, responsible for the increase in downstream TCR-dependent
signals. Overall, these results show that glycine 131 negatively
influences the stability of LAT but it has no bearing on its
sensitivity to Fas-mediated proteolytic cleavage.
Cells Expressing the LATG131D Mutant
Produce Greater Amounts of IL-2 After
CD3/CD28 Stimulation
Lo et al. (2019) have shown that mouse T cells lentivirally
expressing a LAT mutant in which glycine 135 (mouse ortholog
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FIGURE 1 | Mutation of Gly 131 to Asp increases TCR-dependent intracellular signaling. (A) Immunoblots analyzing phosphorylation of LAT at tyrosine residue 132
in cells stimulated with soluble anti-CD3 were done with the phospho-specific antibody. Membranes were stripped and blotted with anti-LAT antibody (middle panel).
The lower diagram represents the mean fold increase in phosphorylation in four independent experiments using J.CaM2 cells expressing WT-LAT (gray line) or the
LATG131D mutant (black line). Phosphorylation levels were normalized to total LAT expression. Bars represent the standard error. The asterisk represents statistical
significance. (B) J.CaM2 cells expressing WT-LAT or the LATG131D mutant were loaded with Indo-1AM and stimulated with OKT3 mAb (1 µg/ml) at the indicated
time (black arrow). The intracellular Ca2+ concentration was determined at 37◦C through the change in Indo-1AM fluorescence. The graphic represents the average
of five experiments. (C) Whole-cell lysates were probed by Western blotting for the activation of Erk by using a mAb recognizing doubly phosphorylated on specific
threonine and tyrosine residues on Erk (upper panel). Stripped membranes were blotted with anti-β-actin mAb to show equal protein expression (middle panel).
Lower diagram represents the mean fold increase in Erk phosphorylation in four independent experiments using J.CaM2 cells expressing WT-LAT (gray line) or the
LATG131D mutant (black line). Phosphorylation levels were normalized to β-actin expression. Bars represent the standard error. Asterisk represents statistical
significance.
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FIGURE 2 | Degradation of WT-LAT and LATG131D mutant proteins. (A) J.CaM2 cells expressing WT-LAT or the LATG131D mutant were treated for the indicated time
in hours at 37◦C with 100 ng/ml of anti-Fas antibody, and LAT cleavage was assessed in total cell lysates by Western blot with an anti-LAT antibody. Molecular
masses in kDa are indicated adjacent to the Western blot. Arrow indicates the band corresponding to the whole LAT molecule, and arrowheads are indicative of the
proteolytic fragments. (B) Cell lysates obtained from J.CaM2 cells expressing WT-LAT or the LATG131D mutant, previously treated with cycloheximide (CHX) for the
indicated time in hours, and LAT (upper panel) or β-actin (middle panel) protein levels were analyzed by Western blot. Black numbers below each panel represent the
quantification of corresponding bands. Red numbers below LAT panel represent the percentage of LAT expression relative to the one at 0 h of cycloheximide
treatment. Densitometric analysis of six experiments was performed, and the relative expression of LAT was represented (lower panel). Bars represent the standard
error. Asterisks represent statistical significance.
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of human G131) had been substituted by an aspartate residue
(LATG135D mutant) have a lower reactivity threshold to allow for
IFN-γ production, and show augmented percentages of IFN-γ
secreting cells. However, it remains to be determined the effect
of this mutation on interleukin-2 (IL-2) secretion. IL-2 is an
essential cytokine that allows controlling the differentiation and
homeostasis of both pro- and anti-inflammatory T cells (Ross and
Cantrell, 2018). Therefore, we cultured J.CaM2 cells expressing
wild-type LAT or the LATG131D mutant for 24 and 48 h with anti-
CD3/anti-CD28 beads. Supernatants were analyzed by ELISA,
and the amount of IL-2 in supernatants from WT-LAT expressing
cells after 24 h of CD3/CD28 stimulation was 15 ± 7 pg/ml
(Figure 3), which constitutes a similar level of IL-2 production
in stimulated J.CaM2 cells expressing LAT (Klossowicz et al.,
2014). Interestingly, supernatants from J.CaM2 cells expressing
the LATG131D mutant stimulated for 24 h contained increased
levels of IL-2 levels with regard to WT-LAT expressing cells
(37 ± 17 pg/ml, Figure 3), although this difference did not reach
statistical significance, probably as the result of the low number
of performed experiments (n = 4). Interestingly, analysis of
supernatants from cells stimulated for 48 h with anti-CD3/anti-
CD28 microbeads showed greater amounts of secreted IL-2
in both types of cells, with a statistically significant difference
between WT-LAT and LATG131D expressing cells (30 ± 4 vs
71± 14 pg/ml, respectively; Figure 3).
However, although it has been previously shown that there
is no basal expression of LAT in J.CaM2 cells, we previously
reported that activation of protein kinase C (PKC) with PMA
induces LAT re-expression at both mRNA and protein levels
(Marek-Bukowiec et al., 2016). To rule out that endogenous LAT
was not expressed, which may confound the observed results, we
decided to stimulate the cells during one night with two doses of
anti-CD3 immobilized to plastic, and verify by Western blot LAT
expression. The endogenous form is smaller than the transfected
LAT forms. As shown in Supplementary Figure S3, treatment
with 2 or 10 µg/ml of OKT3 did not induce expression of the
endogenous form of LAT, discarding any effect of endogenous
LAT expression. Therefore, these results support a role of glycine
131 of LAT as a “brake” controlling not only early intracellular
signals coming from the TCR but also late activation events that
take place in fully activated T cells.
Effect of the Gly 131 to Asp Mutation in
LAT Adaptor on Anergy Induction
It has been previously demonstrated that the integration of
calcium signals with activation of other signaling pathways
results in full activation of T cells, while unopposed calcium
signaling leads to anergy (Macian et al., 2002; Baine et al.,
2009). Anergy is an essential mechanism of peripheral tolerance,
established when the TCR is engaged in the absence of a
CD28-mediated costimulatory signals. Evidence indicates that
calcium signaling is responsible for the establishment of anergy
in T cells. Given that J.CaM2 cells expressing the LATG131D
mutant show increased PLC-γ activation and Ca2+ responses (Lo
et al., 2019), it was of interest to study the relationship of this
mutation with anergy. J.CaM2 or Jurkat cells are not the best
models to analyze the anergy potential, because these cell lines
proliferate continuously in a TCR independent way. However,
we have shown that lentivirally transduced J.CaM2 cells can
secrete IL-2 in response to CD3/CD28 stimulation, allowing us
to study if anti-CD3 pretreatment has any effect on CD3/CD28-
mediated IL-2 production. To do so, J.CaM2 cells lentivirally
transduced to express WT-LAT or the LATG131D mutant were
FIGURE 3 | Increased capacity of IL-2 production by J.CaM2 cells expressing the LATG131D mutant. J.CaM2 cells expressing human WT-LAT or the LATG131D
mutant were stimulated with anti-CD3/CD28 microbeads for the indicated time in hours, and the amount of IL-2 in supernatants was measured by ELISA. The
values presented are mean values of four (for 24 h incubation) or eleven (for 48 h) separate experiments. Bars represent the standard error. The asterisk represents
statistical significance.
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FIGURE 4 | Anergy induction in J.CaM2 cells expressing the LATG131D mutant. (A) Anergy was induced in J.CaM2 cells expressing human WT-LAT or the LATG131D
mutant by culturing cells overnight on plates with the indicated doses of the immobilized anti-CD3 antibody. Recovered cells were then stimulated with
anti-CD3/CD28 microbeads for 48, and the amount of IL-2 in supernatants was measured by ELISA. The values presented are the mean values of four independent
experiments. Bars represent the standard error. (B) The relative effect of anti-CD3 treatment on IL-2 production in cells expressing WT-LAT or the LATG131D mutant.
Maximal IL-2 production in cells treated without anti-CD3 mAb (0 µg/ml) for each type of cell was considered 100%, and the relative production of IL-2 was
calculated for each cell type and condition. (C) Caspase 3 and PTP1B levels in cells treated overnight with the indicated doses of immobilized anti-CD3 antibody
were analyzed by Western blot (upper panels). Stripped membranes were blotted with anti-β-actin mAb to show equal protein expression (lower panels). The
numbers below each panel represent the quantification of corresponding bands. Representative images from one of the three experiments performed with similar
results.
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pretreated overnight with 2 or 10 µg/ml of immobilized anti-CD3
mAb, and then washed and stimulated with anti-CD3/CD28
microbeads for 48 h. IL-2 in the corresponding supernatants
was then measured by ELISA. LATG131D expressing cells without
anti-CD3 “anergizing” pretreatment (Figure 4A, 0 µg/ml of
anti-CD3) produced 63 ± 6 pg/ml of IL-2, while WT-LAT
expressing cells produced a statistically significant lower amount
of IL-2 (30 ± 4 pg/ml). Overnight pretreatment of cells with
10 µg/ml of anti-CD3 reduced the amount of IL-2 produced
by both types of cells by approximately half (16 ± 3 pg/ml
for WT-LAT and 33 ± 4 pg/ml the LATG131D, Figure 4A).
Interestingly, pretreatment of WT-LAT expressing cells with a
lower concentration of anti-CD3 (2 µg/ml) induced a modest
decrease on IL-2 production by WT-LAT expressing cells
(from 30 ± 4 pg/ml to 25 ± 6 pg/ml, Figure 4A), while
the same treatment in LATG131D expressing cells still reduced
by approximately half IL-2 production (from 63 ± 6 pg/ml
to 34 ± 2 pg/ml, Figure 4A). Data in Figure 4A were
recalculated to show the relative effect on the maximal IL-2
production of anti-CD3 pretreatment. Therefore, IL-2 secretion
by both cell types at 0 µg/ml of anti-CD3 pretreatment were
considered 100 percent of IL-2, and the amounts of IL-2 at
10 and 2 µg/ml of anti-CD3 were recalculated. As it can be
seen in Figure 4B, pretreatment with 2 µg/ml of anti-CD3
reduced the IL-2 production by LATG131D expressing cells from
100% to 54% ± 4, while the same treatment had a reduced
effect on WT-LAT expressing cells (from 100 to 84% ± 19).
Therefore, these data demonstrate that pretreatment of LATG131D
expressing cells with anti-CD3 antibodies produces a relative
reduction in IL-2 secretion significantly greater than in cells
expressing WT-LAT. The up-regulation of genes coding for
caspase 3 and the phosphatase PTP1B has been previously
correlated with anergy (Dominguez-Villar et al., 2007). To
confirm the prediction that LATG131D mutant could have a pro-
anergic effect, we analyzed caspase 3 and PTP1B expression by
Western blot in cell lysates obtained after overnight treatment
with 2 and 10 µg/ml of anti-CD3. As it can be seen in
Figure 4C, J.CaM2 cells expressing the LATG131D mutant
show increased basal levels of both caspase 3 and PTP1B
with regard to WT-LAT expressing cells. Moreover, anti-CD3
stimulation also induced higher caspase 3 levels in LATG131D
than in WT-LAT expressing cells, which endorses the pro-
anergic effect of the Gly to Asp mutation of the amino acid
preceding Tyr132 in LAT.
Overall, our data support previous results recently published
by Arthur Weiss and co-workers (Lo et al., 2019). We have
verified that cells expressing the LATG131D mutant show a
significant and specific increase in LAT-Y132 phosphorylation.
As a consequence, PLC-γ activation, Ca2+ influx generation, and
Erk phosphorylation are augmented in LATG131D expressing cells
after CD3-mediated stimulation. Interestingly, we have shown
that this mutation, which prevents the binding to LAT of the
specific mAb LAT-01, increases the stability of this protein.
The increased LAT protein stability provided by the G131D
mutation is in line with our previous published data (Arbulo-
Echevarria et al., 2018). We have analyzed the role of a negatively
charged segment of amino acids in LAT, which is very close to
Gly 131. The substitution of this segment with a sequence of
non-charged residues significantly decreased LAT stability. Now,
we have demonstrated that introducing a negatively charged
residue increases LAT stability. This increase in LAT stability
could be related, at least in part, to the observed increase in
activation events triggered after TCR engagement in LATG131D
expressing cells. More experiments should clarify whether this
is related to the introduction of a negative charge or to the
removal of the glycine residue. Last, we have shown that
substitution of glycine 131 by an aspartate residue enhances
IL-2 production. Lo et al. have previously shown that this
mutation lowers the reactivity threshold to allow for an increased
percentage of cells producing IFN-γ, with notable differences
when cells were stimulated with low-affinity peptides (Lo et al.,
2019). Here we demonstrate that full activation of J.CaM2 cells
expressing LATG131D mutant with anti-CD3/CD28 microbeads
induces statistically significant greater amount of secreted IL-
2. Moreover, we have shown that these cells show an enhanced
predisposition to CD3-mediated inhibition of IL-2 production,
which could be related to anergy in primary cells. This could
be of immunological relevance, since to our knowledge, this is
the earliest signaling event described to be related to anergy.
Although Jurkat and J.CaM2 cell lines are not the best models
for anergy studies, until in vivo analysis can be performed, our
approach is a straightforward attempt to predict if anergy is
affected by mutation of Gly 131. Other groups have analyzed
different aspects of anergy using Jurkat cells (Tzachanis et al.,
2001; Howe et al., 2003; Sundstrom et al., 2005; Dominguez-
Villar et al., 2007; Li et al., 2010; Hsu et al., 2014; Liu et al.,
2016; Sanchez-Del Cojo et al., 2017; Wang et al., 2019), which
gives support to our experimental approach. The greater relative
inhibition of IL-2 secretion shown by J.CaM2 cells expressing
the LATG131D mutant supports this hypothesis, as it does the
increased levels of caspase 3 and PTP1B. Future analysis of anergy
induction in knockin mice expressing the same mutant LAT
isoform would be useful to confirm these data, and this would
constitute an invaluable model with which to analyze the role of
anergy in the maintenance of tolerance and its implications for
autoimmune disorders.
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FIGURE S1 | Expression of WT-LAT and LATG131D in J.CaM2 cells. (A) Schematic
representation of the lentiviral vectors used to express WT-LAT and the LATG131D
mutant in J.CaM2 cells. (B) Histograms of GFP and CD3 expression in lentivirally
transduced J.CaM2 cells expressing WT-LAT (green line) or LATG131D mutant
(black line). Numbers in the histograms represent the percentage of positive cells.
(C) Non transduced J.CaM2 and J.CaM2 cells expressing WT-LAT or the
LATG131D mutant were lysed and LAT expression was analyzed by Western blot
with the anti-LAT mAb LAT-01 (left upper panel), anti-6His (middle upper panel),
and the 11B.12 anti-LAT mAb (right upper panel). Membranes were stripped and
blotted with anti-β-actin mAb to show equal protein load (lower panels).
FIGURE S2 | Specific increase in TCR signaling in J.CaM2 cells expressing the
LATG131D mutant. (A) Immunoblots analyzing phosphorylation of LAT at tyrosine
residue 171 in cells stimulated with soluble anti-CD3 were done with
phospho-specific antibody. Equal amounts of the same samples were run in
parallel and analyzed for total LAT expression by Western blot (lower panel).
Numbers below each panel represent quantification of corresponding bands.
Representative images from one of the three experiments performed with similar
results. (B) Western blot analysis of PLC-γ activation (upper panel). Membranes
were stripped and blotted with anti-β-actin mAb to show equal protein load (lower
panel). Numbers below each panel represent quantification of corresponding
bands. Representative images from one of the three experiments performed with
similar results. (C) J.CaM2 cells expressing WT-LAT or the LATG131D mutant were
loaded with Indo-1AM and stimulated with the indicated concentrations of
anti-CD3 mAb at the indicated time (black arrows). The intracellular Ca2+
concentration was determined at 37◦C through the change in Indo-1AM
fluorescence. Graphs represent the average of 3 and 5 experiments, for OKT3
concentrations of 0.5 and 0.125 µg, respectively.
FIGURE S3 | Stable expression of LAT after long-term CD3-stimulation.
Immunoblots analyzing expression of LAT (upper panel) and β-actin (lower panel)
in cells treated overnight with the indicated doses of immobilized anti-CD3
antibody. Molecular weights in kDa are indicated on the side of the upper panel.
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